MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/jaha.124.036429

Медицинская библиотека · Journal of the American Heart Association · 2024

Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.

Diener Hans Christoph, Becher Nina, Sehner Susanne, Toennis Tobias, Bertaglia Emanuele, Blomstrom-Lundqvist Carina, Brandes Axel, Beuger Vincent, Calvert Melanie, Camm A John, Chlouverakis Gregory, Dan Gheorghe-Andrei, Dichtl Wolfgang, Fierenz Alexander, Goette Andreas, de Groot Joris R, Hermans Astrid, Lip Gregory Y H, Lubinski Andrzej, Marijon Eloi, Merkely Béla, Mont Lluís, Nikorowitsch Julius, Ozga Ann-Kathrin, Rajappan Kim, Sarkozy Andrea, Scherr Daniel, Schnabel Renate B, Schotten Ulrich, Simantirakis Emmanuel, Vardas Panos, Wichterle Dan, Zapf Antonia, Kirchhof Paulus, NOAH‐AFNET 6 investigators

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Short and rare episodes of atrial fibrillation (AF) are commonly detected using implanted devices (device-detected AF) in patients with prior stroke or transient ischemic attack (TIA). The effectiveness and safety of oral anticoagulation in patients with prior stroke or TIA and device-detected AF but with no ECG-documented AF is unclear.

METHODS AND

RESULTS

This prespecified analysis of the NOAH-AFNET 6 (Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes) trial with post hoc elements assessed the effect of oral anticoagulation in patients with device-detected AF with and without a prior stroke or TIA in the randomized, double-blind, double-dummy NOAH-AFNET 6 trial. Outcomes were stroke, systemic embolism, and cardiovascular death (primary outcome) and major bleeding and death (safety outcome). A prior stroke or TIA was found in 253 patients with device-detected AF randomized in the NOAH-AFNET 6 (mean age, 78 years; 36.4% women). There was no treatment interaction with prior stroke or TIA for any of the primary and secondary time-to-event outcomes. In patients with a prior stroke or TIA, 14 out of 122 patients experienced a primary outcome event with anticoagulation (5.7% per patient-year). Without anticoagulation, there were 16 out of 131 patients with an event (6.3% per patient-year). The rate of stroke was lower than expected (anticoagulation: 4 out of 122 [1.6% per patient-year]; no anticoagulation: 6 out of 131 [2.3% per patient-year]). Numerically, there were more major bleeding events with anticoagulation in patients with prior stroke or TIA (8 out of 122 patients) than without anticoagulation (2 out of 131 patients).

CONCLUSIONS

Anticoagulation appears to have ambiguous effects in patients with device-detected AF and a prior stroke or TIA in this hypothesis-generating analysis of the NOAH-AFNET 6 in the absence of ECG-documented AF, partially due to a low rate of stroke without anticoagulation.

Для цитирования: Diener Hans Christoph, Becher Nina, Sehner Susanne, Toennis Tobias, Bertaglia Emanuele, Blomstrom-Lundqvist Carina, Brandes Axel, Beuger Vincent, Calvert Melanie, Camm A John, Chlouverakis Gregory, Dan Gheorghe-Andrei, Dichtl Wolfgang, Fierenz Alexander, Goette Andreas, de Groot Joris R, Hermans Astrid, Lip Gregory Y H, Lubinski Andrzej, Marijon Eloi, Merkely Béla, Mont Lluís, Nikorowitsch Julius, Ozga Ann-Kathrin, Rajappan Kim, Sarkozy Andrea, Scherr Daniel, Schnabel Renate B, Schotten Ulrich, Simantirakis Emmanuel, Vardas Panos, Wichterle Dan, Zapf Antonia, Kirchhof Paulus, NOAH‐AFNET 6 investigators. Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.. Journal of the American Heart Association. 2024. DOI: 10.1161/jaha.124.036429.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.